Seletracetam (ucb 44212) inhibits high-voltage-activated Ca2+ currents and intracellular Ca2+ increase in rat cortical neurons in vitro

Giuseppina Martella, Paola Bonsi, Giuseppe Sciamanna, Paola Platania, Graziella Madeo, Annalisa Tassone, Dario Cuomo, Antonio Pisani

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Purpose: We analyzed the effects of seletracetam (ucb 44212; SEL), a new antiepileptic drug candidate, in an in vitro model of epileptic activity. The activity of SEL was compared to the effects of levetiracetam (LEV; Keppra), in the same assays. Methods: Combined electrophysiologic and microfluorometric recordings were performed from layer V pyramidal neurons in rat cortical slices to study the effects of SEL on the paroxysmal depolarization shifts (PDSs), and the simultaneous elevations of intracellular Ca2+ concentration [Ca2+]i. Moreover, the involvement of high-voltage activated Ca2+ currents (HVACCs) was investigated by means of patch-clamp recordings from acutely dissociated pyramidal neurons. Results: SEL significantly reduced both the duration of PDSs (IC50 = 241.0 ± 21.7 nm) as well as the number of action potentials per PDS (IC 50 = 82.7 ± 9.7 nm). In addition, SEL largely decreased the [Ca2+]i rise accompanying PDSs (up to 75% of control values, IC50 = 345.0 ± 15.0 nm). Furthermore, SEL significantly reduced HVACCs in pyramidal neurons. This effect was mimicked by ω-conotoxin GVIA and, to a lesser extent, by ω-conotoxin MVIIC, blockers of N- and Q-type HVACC, respectively. The combination of these two toxins occluded the action of SEL, suggesting that N-type Ca2+ channels, and partly Q-type subtypes are preferentially targeted. Conclusions: These results demonstrate a powerful inhibitory effect of SEL on epileptiform events in vitro. SEL showed a higher potency than LEV. The effective limitation of [Ca2+]i influx might be relevant for its antiepileptic efficacy and, more broadly, for pathologic processes involving neuronal [Ca 2+]i overload.

Original languageEnglish
Pages (from-to)702-710
Number of pages9
JournalEpilepsia
Volume50
Issue number4
DOIs
Publication statusPublished - Apr 2009

Fingerprint

etiracetam
Pyramidal Cells
Conotoxins
Neurons
Anticonvulsants
Inhibitory Concentration 50
Pathologic Processes
Action Potentials
In Vitro Techniques
Seletracetam

Keywords

  • Acutely dissociated neuron
  • Calcium imaging
  • Epileptiform activity
  • Levetiracetam
  • Pyramidal neuron
  • Slice

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Seletracetam (ucb 44212) inhibits high-voltage-activated Ca2+ currents and intracellular Ca2+ increase in rat cortical neurons in vitro. / Martella, Giuseppina; Bonsi, Paola; Sciamanna, Giuseppe; Platania, Paola; Madeo, Graziella; Tassone, Annalisa; Cuomo, Dario; Pisani, Antonio.

In: Epilepsia, Vol. 50, No. 4, 04.2009, p. 702-710.

Research output: Contribution to journalArticle

Martella, Giuseppina ; Bonsi, Paola ; Sciamanna, Giuseppe ; Platania, Paola ; Madeo, Graziella ; Tassone, Annalisa ; Cuomo, Dario ; Pisani, Antonio. / Seletracetam (ucb 44212) inhibits high-voltage-activated Ca2+ currents and intracellular Ca2+ increase in rat cortical neurons in vitro. In: Epilepsia. 2009 ; Vol. 50, No. 4. pp. 702-710.
@article{9d40740867574cfaa60cb45d835363f5,
title = "Seletracetam (ucb 44212) inhibits high-voltage-activated Ca2+ currents and intracellular Ca2+ increase in rat cortical neurons in vitro",
abstract = "Purpose: We analyzed the effects of seletracetam (ucb 44212; SEL), a new antiepileptic drug candidate, in an in vitro model of epileptic activity. The activity of SEL was compared to the effects of levetiracetam (LEV; Keppra), in the same assays. Methods: Combined electrophysiologic and microfluorometric recordings were performed from layer V pyramidal neurons in rat cortical slices to study the effects of SEL on the paroxysmal depolarization shifts (PDSs), and the simultaneous elevations of intracellular Ca2+ concentration [Ca2+]i. Moreover, the involvement of high-voltage activated Ca2+ currents (HVACCs) was investigated by means of patch-clamp recordings from acutely dissociated pyramidal neurons. Results: SEL significantly reduced both the duration of PDSs (IC50 = 241.0 ± 21.7 nm) as well as the number of action potentials per PDS (IC 50 = 82.7 ± 9.7 nm). In addition, SEL largely decreased the [Ca2+]i rise accompanying PDSs (up to 75{\%} of control values, IC50 = 345.0 ± 15.0 nm). Furthermore, SEL significantly reduced HVACCs in pyramidal neurons. This effect was mimicked by ω-conotoxin GVIA and, to a lesser extent, by ω-conotoxin MVIIC, blockers of N- and Q-type HVACC, respectively. The combination of these two toxins occluded the action of SEL, suggesting that N-type Ca2+ channels, and partly Q-type subtypes are preferentially targeted. Conclusions: These results demonstrate a powerful inhibitory effect of SEL on epileptiform events in vitro. SEL showed a higher potency than LEV. The effective limitation of [Ca2+]i influx might be relevant for its antiepileptic efficacy and, more broadly, for pathologic processes involving neuronal [Ca 2+]i overload.",
keywords = "Acutely dissociated neuron, Calcium imaging, Epileptiform activity, Levetiracetam, Pyramidal neuron, Slice",
author = "Giuseppina Martella and Paola Bonsi and Giuseppe Sciamanna and Paola Platania and Graziella Madeo and Annalisa Tassone and Dario Cuomo and Antonio Pisani",
year = "2009",
month = "4",
doi = "10.1111/j.1528-1167.2008.01915.x",
language = "English",
volume = "50",
pages = "702--710",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Blackwell Publishing Inc.",
number = "4",

}

TY - JOUR

T1 - Seletracetam (ucb 44212) inhibits high-voltage-activated Ca2+ currents and intracellular Ca2+ increase in rat cortical neurons in vitro

AU - Martella, Giuseppina

AU - Bonsi, Paola

AU - Sciamanna, Giuseppe

AU - Platania, Paola

AU - Madeo, Graziella

AU - Tassone, Annalisa

AU - Cuomo, Dario

AU - Pisani, Antonio

PY - 2009/4

Y1 - 2009/4

N2 - Purpose: We analyzed the effects of seletracetam (ucb 44212; SEL), a new antiepileptic drug candidate, in an in vitro model of epileptic activity. The activity of SEL was compared to the effects of levetiracetam (LEV; Keppra), in the same assays. Methods: Combined electrophysiologic and microfluorometric recordings were performed from layer V pyramidal neurons in rat cortical slices to study the effects of SEL on the paroxysmal depolarization shifts (PDSs), and the simultaneous elevations of intracellular Ca2+ concentration [Ca2+]i. Moreover, the involvement of high-voltage activated Ca2+ currents (HVACCs) was investigated by means of patch-clamp recordings from acutely dissociated pyramidal neurons. Results: SEL significantly reduced both the duration of PDSs (IC50 = 241.0 ± 21.7 nm) as well as the number of action potentials per PDS (IC 50 = 82.7 ± 9.7 nm). In addition, SEL largely decreased the [Ca2+]i rise accompanying PDSs (up to 75% of control values, IC50 = 345.0 ± 15.0 nm). Furthermore, SEL significantly reduced HVACCs in pyramidal neurons. This effect was mimicked by ω-conotoxin GVIA and, to a lesser extent, by ω-conotoxin MVIIC, blockers of N- and Q-type HVACC, respectively. The combination of these two toxins occluded the action of SEL, suggesting that N-type Ca2+ channels, and partly Q-type subtypes are preferentially targeted. Conclusions: These results demonstrate a powerful inhibitory effect of SEL on epileptiform events in vitro. SEL showed a higher potency than LEV. The effective limitation of [Ca2+]i influx might be relevant for its antiepileptic efficacy and, more broadly, for pathologic processes involving neuronal [Ca 2+]i overload.

AB - Purpose: We analyzed the effects of seletracetam (ucb 44212; SEL), a new antiepileptic drug candidate, in an in vitro model of epileptic activity. The activity of SEL was compared to the effects of levetiracetam (LEV; Keppra), in the same assays. Methods: Combined electrophysiologic and microfluorometric recordings were performed from layer V pyramidal neurons in rat cortical slices to study the effects of SEL on the paroxysmal depolarization shifts (PDSs), and the simultaneous elevations of intracellular Ca2+ concentration [Ca2+]i. Moreover, the involvement of high-voltage activated Ca2+ currents (HVACCs) was investigated by means of patch-clamp recordings from acutely dissociated pyramidal neurons. Results: SEL significantly reduced both the duration of PDSs (IC50 = 241.0 ± 21.7 nm) as well as the number of action potentials per PDS (IC 50 = 82.7 ± 9.7 nm). In addition, SEL largely decreased the [Ca2+]i rise accompanying PDSs (up to 75% of control values, IC50 = 345.0 ± 15.0 nm). Furthermore, SEL significantly reduced HVACCs in pyramidal neurons. This effect was mimicked by ω-conotoxin GVIA and, to a lesser extent, by ω-conotoxin MVIIC, blockers of N- and Q-type HVACC, respectively. The combination of these two toxins occluded the action of SEL, suggesting that N-type Ca2+ channels, and partly Q-type subtypes are preferentially targeted. Conclusions: These results demonstrate a powerful inhibitory effect of SEL on epileptiform events in vitro. SEL showed a higher potency than LEV. The effective limitation of [Ca2+]i influx might be relevant for its antiepileptic efficacy and, more broadly, for pathologic processes involving neuronal [Ca 2+]i overload.

KW - Acutely dissociated neuron

KW - Calcium imaging

KW - Epileptiform activity

KW - Levetiracetam

KW - Pyramidal neuron

KW - Slice

UR - http://www.scopus.com/inward/record.url?scp=64049087839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64049087839&partnerID=8YFLogxK

U2 - 10.1111/j.1528-1167.2008.01915.x

DO - 10.1111/j.1528-1167.2008.01915.x

M3 - Article

C2 - 19055493

AN - SCOPUS:64049087839

VL - 50

SP - 702

EP - 710

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - 4

ER -